An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease

An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease Publisher

Rostami T¹ ; Kiumarsi A¹

Source: Pediatric Reports Published:2020

Abstract

Allogeneic hematopoietic stem-cell transplantation is a well-known curative treatment for patients with chronic granulomatous disease. We present our experiment regarding ten patients with chronic granulomatous disease who underwent a reduced intensity conditioning regimen consisting of melfalan, fludarabine, and antithymocyte globulin. Donor lymphocyte infusion was used in three representative patients who developed mixed donor chimerism. After at least 2 years of median follow-up, 8 of the 10 patients are alive and well. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Related Docs

View other Related Docs

1. A Fludarabine and Melphalan Reduced-Intensity Conditioning Regimen for Hsct in Fifteen Chronic Granulomatous Disease Patients and a Literature Review, Annals of Hematology (2022)

2. Long-Term Outcomes of Fludarabine, Melphalan and Antithymocyte Globulin As Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Primary Immunodeficiency Disorders: A Prospective Single Center Study, Bone Marrow Transplantation (2016)

3. Escalated Dose Donor Lymphocyte Infusion Treatment in Patients With Primary Immune Deficiencies After Hsct With Reduced-Intensity Conditioning Regimen, Hematology/ Oncology and Stem Cell Therapy (2022)

Experts (# of related papers)

View all Related Experts

Amir Ali Hamidieh (5)

Maryam Behfar (4)

Style	Citing Format
MLA	Rostami T, Kiumarsi A. "An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease." Pediatric Reports, vol. 12, no. 3, 2020, pp. 149-154.
APA	Rostami T, Kiumarsi A (2020). An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. Pediatric Reports, 12(3), 149-154.
Chicago	Rostami T, Kiumarsi A. "An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease." Pediatric Reports 12, no. 3 (2020): 149-154.
Harvard	Rostami T, Kiumarsi A (2020) 'An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease', Pediatric Reports, 12(3), pp. 149-154.
Vancouver	Rostami T, Kiumarsi A. An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. Pediatric Reports. 2020;12(3):149-154.
BibTex	@article{ author = {Rostami T and Kiumarsi A}, title = {An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease}, journal = {Pediatric Reports}, volume = {12}, number = {3}, pages = {149-154}, year = {2020} }
RIS	TY - JOUR AU - Rostami T AU - Kiumarsi A TI - An Experience of Donor Lymphocyte Infusion After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease JO - Pediatric Reports VL - 12 IS - 3 SP - 149 EP - 154 PY - 2020 ER -

Science Communicator Platform

Authors

Abstract